期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人端粒酶RNA组分基因在子宫颈和食管鳞状上皮内瘤变中表达的研究进展

原文传递
导出
摘要 人端粒酶RNA组分（human telomerase RNA component,hTERC）基因是端粒酶的组成成分之一,其作用是作为端粒酶延长的RNA模板。鳞状上皮内瘤变是指鳞状上皮结构和细胞的异常,属于癌前病变,而子宫颈和食管是发生鳞状上皮内瘤变最常见的部位。子宫颈癌是全球第二大妇科恶性肿瘤,具有发病率高、死亡率高和年轻化的趋势[1],其中鳞状细胞癌占80%～85%。食管鳞状细胞癌是消化道常见肿瘤,
作者 周军 马捷 王建东
机构地区 南京大学医学院临床学院/南京军区南京总医院病理科
出处 《诊断学理论与实践》 2012年第6期630-632,共3页 Journal of Diagnostics Concepts & Practice
关键词 人端粒酶RNA基因 人端粒酶RNA基因 鳞状上皮 子宫颈 食管 上皮内瘤变
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1季成萍,吴强,孙志华,赵一兵,邵衡华.年轻Ⅰb～Ⅱb期高危宫颈癌术前同步放化疗的疗效分析[J].医学研究生学报,2009,22(10):1056-1059. 被引量：9
  • 2Soder AI, Going JJ, Kaye SB, et al. Tumour specific regulation of telomerasc RNA gene expression visualized by in situ hybridization[J]. Oncogene,1998,16(8):979-983.
  • 3Kubota M, Yamana H, Sueyoshi S, et al. The significance of telomerase activity in cancer lesions and the noncan- cerous epithelium of the esophagus[J]. Int J Clin Oncol, 2002,7(1):32-37.
  • 4Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer[J]. Science,1994,266(5193):2011-2015.
  • 5Cao Y, Bryan TM, Reddel RR. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells[J]. Cancer Sci,2008,99(6):1092-1099.
  • 6Counter CM, Meyerson M, Eaton EN, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (bEST2), the catalytic subunit of telomerase[J]. Oncogene, 1998,16(9): 1217-1222.
  • 7Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up- regulated in tumor cells and during immortalization [J]. Cell, 1997,90(4):785-795.
  • 8Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells[J]. Science, 1998,279(5349):349-352.
  • 9Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase[J]. Science,1995,269(5228):1236-1241.
  • 10Rooney PH, Murray GI, Stevenson DA, et al. Comparative genomic hybridization and chromosomal instability in solid turnouts[J]. Br J Cancer,1999,80(5-6):862-873.

二级参考文献15

  • 1姜继勇,陈雪莲.青年人宫颈癌临床病理特征和预后的研究[J].临床肿瘤学杂志,2005,10(1):45-48. 被引量：6
  • 2Jurado M,Martinez MR,Garcia FJ,et al.Pilot study of concurrent cisplatin,5-fluorouracil and external beam radio therapy prior to radical surgery+/-intraoperative electron bean radiotherapy in locally advanced cervical cancer[J].Gynecol Oncol,1999,74(1):30-37.
  • 3Horn LC,Fischer U,Bilck K.Histopathological prognostic factors in primary surgically treated cervix carcinoma[J].ZentralblGynakol,2001,123(5):266-274.
  • 4Toita T,Mitsuhashi N,Teshima T,et al.Postoperative radiotherapy for uterine cervical cancer; results of the 1995-1997 patterns of care process survey in Japan[J].Jpn J Clin Oncol,2004,34(2):99-103.
  • 5Modarress M,Maghami FQ,Golnavaz M,et al.Comparative study of chemoradiation and neoadjuvant chemotherapy effect before radical hysterectomy in stage ⅠB-ⅡB bulky cervical cancer and with tumor diameter greater than 4 cm[J].Int J Gynecol Cancer,2005,15(3):483-488.
  • 6Rouzier R,Morice P,De Crevoisier R,et al.Survival in cervix cancer patients treated with radiotherapy followed by radical surgery[J].Eur J Surg Oncol,2005,31(4):424-433.
  • 7Bernard A,Touboul E,Lefranc JP,et al.Epidermoid carcinoma of the uterine cervix at operable bulky stages ⅠB and Ⅱ treated with combined primary radiation therapy and surgery[J].Cancer Radiother,2002,6(2):85-98.
  • 8Lorvidhaya V,Chitapanarux I,Sangruchi S,et al.Concurrent mitomycin C,5-fluorouracil,and radiotherapy in the treatment of locally advanced carcinoma of the cervix:a randomized trial[J].Int J Radiat Oncol Biol Phys,2003,55(5):1226-1232.
  • 9Souza NM,Soutter WP,Rustin G,et al.Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer:monitoring tumor shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome[J].Br J Cancer,2004,90(12):2326-2331.
  • 10Eddy GL,Bundy BN,Creasman WT,et al.Treatment of ("bulkly") stage Ⅰb cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic /para-aortic lymphadenectomy:a phase Ⅲ trial of the gynecologic oncology group[J].Gynecol Oncol,2007,106(2):362-369.

共引文献8

诊断学理论与实践
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部